Whole-Genome Analyses of Enterococcus faecium Isolates with Diverse Daptomycin MICs
Open Access
- 1 August 2014
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 58 (8), 4527-4534
- https://doi.org/10.1128/aac.02686-14
Abstract
Daptomycin (DAP) is a lipopeptide antibiotic frequently used as a “last-resort” antibiotic against vancomycin-resistant Enterococcus faecium (VRE). However, an important limitation for DAP therapy against VRE is the emergence of resistance during therapy. Mutations in regulatory systems involved in cell envelope homeostasis are postulated to be important mediators of DAP resistance in E. faecium. Thus, in order to gain insights into the genetic bases of DAP resistance in E. faecium, we investigated the presence of changes in 43 predicted proteins previously associated with DAP resistance in enterococci and staphylococci using the genomes of 19 E. faecium with different DAP MICs (range, 3 to 48 μg/ml). Bodipy-DAP (BDP-DAP) binding to the cell membrane assays and time-kill curves (DAP alone and with ampicillin) were performed. Genetic changes involving two major pathways were identified: (i) LiaFSR, a regulatory system associated with the cell envelope stress response, and (ii) YycFGHIJ, a system involved in the regulation of cell wall homeostasis. Thr120→Ala and Trp73→Cys substitutions in LiaS and LiaR, respectively, were the most common changes identified. DAP bactericidal activity was abolished in the presence of liaFSR or yycFGHIJ mutations regardless of the DAP MIC and was restored in the presence of ampicillin, but only in representatives of the LiaFSR pathway. Reduced binding of BDP-DAP to the cell surface was the predominant finding correlating with resistance in isolates with DAP MICs above the susceptibility breakpoint. Our findings suggest that genotypic information may be crucial to predict response to DAP plus β-lactam combinations and continue to question the DAP breakpoint of 4 μg/ml.Keywords
This publication has 49 references indexed in Scilit:
- Genotypic and Phenotypic Evaluation of the Evolution of High-Level Daptomycin Nonsusceptibility in Vancomycin-Resistant Enterococcus faeciumAntimicrobial Agents and Chemotherapy, 2012
- Correlation between Mutations in liaFSR of Enterococcus faecium and MIC of Daptomycin: Revisiting Daptomycin BreakpointsAntimicrobial Agents and Chemotherapy, 2012
- The rise of the Enterococcus: beyond vancomycin resistanceNature Reviews Microbiology, 2012
- Genetic Basis for In Vivo Daptomycin Resistance in EnterococciThe New England Journal of Medicine, 2011
- Genetic Basis for Daptomycin Resistance in EnterococciAntimicrobial Agents and Chemotherapy, 2011
- Improved Detection of Candida sp. fks Hot Spot Mutants by Using the Method of the CLSI M27-A3 Document with the Addition of Bovine Serum AlbuminAntimicrobial Agents and Chemotherapy, 2011
- Striking “Seesaw Effect” between Daptomycin Nonsusceptibility and β-Lactam Susceptibility in Staphylococcus haemolyticusAntimicrobial Agents and Chemotherapy, 2011
- Enhanced Expression ofdltABCDIs Associated with the Development of Daptomycin Nonsusceptibility in a Clinical Endocarditis Isolate ofStaphylococcus aureusThe Journal of Infectious Diseases, 2009
- Genetic Analysis of Factors Affecting Susceptibility ofBacillus subtilisto DaptomycinAntimicrobial Agents and Chemotherapy, 2009
- Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2006